摘要
目的评价羟考酮对人结肠癌细胞转移能力的影响及μ、κ受体在其中的作用。方法人结肠癌HCT116细胞,以1×106个/ml的密度接种于24孔板或6孔板,0.5 ml/孔或2 ml/孔,144个培养孔,采用随机数字表法,将其分为6组(n=24):对照组(C组)、1、5、10 μmol/L羟考酮组(O1组、O2组和O3组)、羟考酮+ μ受体拮抗剂CTOP组(O2+CTOP组)、羟考酮+κ受体拮抗剂nor-binaltorphimine组(O2+BNI组)。O1组、O2组和O3组分别采用相应浓度羟考酮孵育,O2+CTOP组和O2+BNI组分别采用5 μmol/L羟考酮+20 μmol/L CTOP或5 μmol/L羟考酮+nor-binaltorphimin 20 μmol/L孵育24 h。测定侵袭细胞数、迁移细胞数、小G蛋白A(RhoA)、小G蛋白Rho相关激酶-1(ROCK1)、基质金属蛋白酶-2(MMP-2)和MMP-9的水平。结果与C组比较,O1组、O2组和O3组侵袭细胞数和迁移细胞数依次降低,细胞RhoA、ROCK1、MMP-2和MMP-9的水平依次降低(P〈0.05),O2+BNI组上述指标比较差异无统计学意义(P〉0.05);与O2组比较,O2+BNI组侵袭细胞数和迁移细胞数增加,细胞RhoA、ROCK1、MMP-2和MMP-9的水平升高(P〈0.05),O2+CTOP组细胞上述指标比较差异无统计学意义(P〉0.05)。结论羟考酮可抑制人结肠癌细胞转移能力,其机制全部与激活κ受体后抑制RhoA/ROCK1通路激活有关,而与μ受体无明显关系。
Objective To evaluate the effect of oxycodone on migration of human colon cancer cells and the role of μ and κ receptors.Methods The human colon cancer HCT116 cells at the logarithmic growth phase were seeded in 24-well or in 6-well plates at a density of 1×106 cells/ml(0.5 ml/well or 2 ml/well, 144 wells in total). The cells were divided into 6 groups(n=24 each)using a random number table: control group(group C), 1, 5 and 10 μmol/L oxycodone groups(group O1, group O2 and group O3), oxycodone plus μ receptor antagonist CTOP group(group O2+ CTOP)and oxycodone plus κ receptor antagonist nor-binaltorphimine group(group O2+ BNI). The cells were incubated for 24 h with oxycodone 1, 5 and 10 μmol/L in O1, O2 and O3 groups, respectively.The cells were incubated for 24 h with 5 μmol/L oxycodone plus 20 μmol/L CTOP and 5 μmol/L oxycodone plus nor-binaltorphimin 20 μmol/L in O2+ CTOP and O2+ BNI groups, respectively.The invaded and migrated cells were counted, and the levels of Ras homolog gene family member A(RhoA), Rho-associated protein kinase 1(ROCK1), matrix metalloproteinase-2(MMP-2)and MMP-9 were detected.Results Compared with group C, the number of invaded and migrated cells was gradually decreased, and the levels of RhoA, ROCK1, MMP-2 and MMP-9 were gradually decreased in O1, O2 and O3 groups(P〈0.05), and no significant change was found in the parameters mentioned above in group O2+ BNI(P〉0.05). Compared with group O2, the number of invaded and migrated cells was significantly increased, and the levels of RhoA, ROCK1, MMP-2 and MMP-9 were increased in group O2+ BNI(P〈0.05), and no significant change was found in the parameters mentioned above in group O2+ CTOP(P〉0.05).Conclusion Oxycodone can inhibit the migration of human colon cancer cells, and the mechanism is totally related to inhibition of RhoA/ROCK1 signaling pathway activation after activating κ receptors, but not related to μ receptors.
出处
《中华麻醉学杂志》
CSCD
北大核心
2017年第4期439-442,共4页
Chinese Journal of Anesthesiology
基金
佛山市科技创新平台资助项目(2014016)
关键词
羟可酮
结肠肿瘤
肿瘤转移
受体
阿片样
K
受体
阿片样
“
Oxycodone
Colonic neoplasms
Neoplasm metastasis
Receptors, opioid, kappa
Receptors, opioid, mu